Understanding BD’s Recent Stock Performance
BD’s stock performance
On October 5, 2017, Becton, Dickinson, and Company (BDX), or BD, closed the day at $197.25 per share. The stock has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.
BD stock was trading at its 52-week high of $206.63 on July 25, 2017. On December 7, 2016, the stock registered its 52-week low of $161.29 per share.
Interested in BDX? Don't miss the next report.
Receive e-mail alerts for new research on BDX
BD released its latest quarterly earnings on August 3, 2017, and the company announced its 3Q17 results on the day. Its revenues came in lower than the Wall Street estimates, which triggered a slight decline in the stock’s price that day, but BD expects to register strong growth in fiscal 2017, with headwinds in 3Q17 not expected to impact future quarters.
BD stock has risen ~19.2% YTD (year-to-date). Over the past six months, the stock has gained 7.6%, but it has fallen 1.4% in the past month.
Peer and industry comparison
In the past 12 months, BD stock has registered a return of ~9.7%, while the S&P 500 Index has gained 17.7% during the same period, and the US medical device sector (IHI) has gained 17.2%.
In the next part, we’ll examine BD’s latest developments in diabetes.